I think that there is also inherent pushback in the western community against anything that is non-big pharma based. When I went to the Tasly research conference, there was a lot of grumbling by the PI's there about the fact that Tasly advanced little to no mechanistic understanding for their herbal drug. Does that matter though? We use many drugs today that we have an incomplete mechanistic understanding, especially mental health drugs like lithium. A clinical study that is overseen by the FDA should speak for itself. You wouldn't have heard similar complaints at a conference hosted by Amgen. And yet, most likely because the suits from the company were chinese and had mediocre english skills, some doctors were combative about enrolling patients.